LQDA NASDAQ
Liquidia Corporation
1W: +28.2%
1M: -36.1%
3M: -49.6%
YTD: +39.3%
1Y: +98.6%
3Y: +658.1%
5Y: +1142.6%
$45.53
+1.79 (+4.10%)
Weekly Expected Move ±33.9%
$14
$28
$43
$57
$72
Credit Risk of going bust: higher than 71% of companies Debt: 3.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.29 (down 99.3%), Liquidia Corporation would be worth roughly what it owes.
Total debt $128.9M against a stock market value of $3.92B.
Distance to default 3.36 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $61.1M (short-term plus half of long-term), stock volatility 109.9%; Altman Z'' 2.90. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.29 (down 99.3%), Liquidia Corporation would be worth roughly what it owes.
Total debt $128.9M against a stock market value of $3.92B.
Distance to default 3.36 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $61.1M (short-term plus half of long-term), stock volatility 109.9%; Altman Z'' 2.90. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.3M
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.9B
52W Range22.05-93.61
Volume4,113,322
Avg Volume2,927,425
Beta0.54
Dividend—
Analyst Ratings
Company Info
CEORoger A. Jeffs
Employees216
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2018-07-26
Websiteliquidia.com
419 Davis Drive
Morrisville, NC 27560
US
Morrisville, NC 27560
US
919 328 4400
About Liquidia Corporation
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
Latest News
Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?
Liquidia Stock Gets Stronger EPS Estimate from HC Wainwright
Liquidia soars 27% after settlement resolves litigation
LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label
Liquidia adds over 30% on United Thera. settlement; BTIG upgrades
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| JEFFS ROGER | S-Sale | 32,744 | $28.48 | 2026-10-12 |
| Boyle Dana | S-Sale | 5,892 | $28.48 | 2026-10-12 |
| Adair Jason | S-Sale | 7,301 | $28.48 | 2026-10-12 |
| Schundler Russell | S-Sale | 13,692 | $28.48 | 2026-10-12 |
| Saggar Rajeev | S-Sale | 9,218 | $28.48 | 2026-10-12 |